Innoviz Technologies (INVZ) Q3 2025: Revenue Soars 238% to $15.3M, Gross Margin Turns Positive, FY25 Outlook Reaffirmed

Innoviz Technologies (INVZ) Q3 2025: Revenue Soars 238% to $15.3M, Gross Margin Turns Positive, FY25 Outlook Reaffirmed

LiDAR maker Innoviz Technologies Ltd. (NASDAQ: INVZ) reported a sharp acceleration in growth and improving unit economics in its third quarter, as management reiterated full‑year targets and highlighted fresh momentum across automotive and non‑automotive programs. Q3 revenue jumped to $15.3 million (up ~238% year over year), gross profit swung positive, and the company underscored a September production selection for Level 4 (L4) Class‑8 autonomous trucks with a major commercial vehicle OEM. [1]

As of 14:57 UTC today, Innoviz shares were trading around $1.57 (−~2.5% intraday). Prices are real‑time/delayed per exchange rules and may update.


Key numbers (Q3 2025)

  • Revenue:$15.3M vs. $4.5M in Q3 2024 (~238% YoY). Year‑to‑date revenue reached $42.4M, ~2.3× the same period last year. [2]
  • Gross profit:$2.3M (approx. 15% gross margin) vs. a small gross loss in Q3 2024, reflecting improving costs and mix. [3]
  • Operating expenses:$18.1M, down 30% YoY; includes $2.4M in share‑based compensation. [4]
  • Net loss / EPS:$15.4M / ($0.08) vs. $24.9M / ($0.15) a year ago. [5]
  • Liquidity (Sept. 30, 2025):$74.4M in cash, deposits, marketable securities and short‑term restricted cash. [6]

Consensus check: Independent coverage noted Q3 revenue beat expectations and EPS came in roughly in line with estimates (−$0.08). [7]


What moved the story today

  • Commercial win in heavy trucks: Innoviz reiterated that a major commercial vehicle OEM selected the company for future series production of L4 Class‑8 autonomous trucks; Innoviz has already begun shipping InnovizTwo units to the OEM’s data‑collection fleet. The OEM name remains undisclosed. [8]
  • Units accelerating: Management said LiDAR shipments rose significantly quarter‑over‑quarter, aligned with plans to ship “an order of magnitude more units” in Q3. [9]
  • Product roadmap: Innoviz is unveiling “InnovizThree”—designed for behind‑the‑windshield integration—with a ~60% reduction in size and improved power/performance versus InnovizTwo. The company also reported traction for InnovizSMART in perimeter security and other non‑automotive uses. [10]

Guidance and outlook

Innoviz reaffirmed FY2025 targets of $50–$60M in revenue (more than 2× 2024), 1–3 new program wins, and $30–$60M in new non‑recurring engineering (NRE) bookings. Management also flagged continued progress on L3 and L4 automotive programs and preparations for a fourth winter‑testing cycle in Northern Europe to support launches. [11]

Earnings call/webcast: The company scheduled its Q3 2025 earnings webcast for 9:00 a.m. ET today; the earnings release and presentation deck were posted to Innoviz’s investor site. A replay will be available. [12]


Why it matters

  • Line of sight to scale: A positive gross margin alongside triple‑digit revenue growth suggests unit economics are trending in the right direction as volumes scale, a key milestone for LiDAR suppliers vying for multi‑year automotive programs. [13]
  • Diversification beyond passenger cars: The L4 trucking selection broadens Innoviz’s end‑market exposure and could bring nearer‑term unit volume compared with some passenger‑vehicle timelines. [14]
  • Product cadence: With InnovizThree aimed at easier integration and lower power draw, the portfolio now spans multiple integration points (including behind‑the‑windshield), which can expand the addressable market across OEM platforms. [15]

What to watch next

  1. OEM reveal & SOP timing: Watch for the identity of the L4 truck OEM and milestones toward series production. [16]
  2. FY25 execution: Delivery against the $50–$60M revenue target and the 1–3 expected new program wins. [17]
  3. Cash runway: Management’s ability to manage cash burn versus the $74.4M liquidity on hand as volumes scale. [18]
  4. Adoption in security/industrial: Evidence that InnovizSMART wins are converting into revenue outside automotive. [19]

Editorial note / disclosure

This article summarizes publicly available information released today (November 12, 2025) and independent coverage; it is not investment advice. Always do your own research and consider speaking with a financial advisor. [20]

Sources: Innoviz press release and IR site; Reuters/Refinitiv summary via TradingView; real‑time market data. [21]

This $1 Tech Stock is Set to Explode in 2025 – Here’s How

References

1. www.prnewswire.com, 2. www.prnewswire.com, 3. www.prnewswire.com, 4. www.prnewswire.com, 5. www.prnewswire.com, 6. www.prnewswire.com, 7. www.tradingview.com, 8. www.prnewswire.com, 9. www.prnewswire.com, 10. www.prnewswire.com, 11. www.prnewswire.com, 12. ir.innoviz.tech, 13. www.prnewswire.com, 14. www.prnewswire.com, 15. www.prnewswire.com, 16. www.prnewswire.com, 17. www.prnewswire.com, 18. www.prnewswire.com, 19. www.prnewswire.com, 20. www.prnewswire.com, 21. www.prnewswire.com

Stock Market Today

  • On Holding stock jumps ~20% after Q3 beat; raises full-year outlook on strong momentum into holidays
    November 12, 2025, 12:26 PM EST. On Holding AG (ONON) shares rose about 20% after Q3 results topped forecasts and the company lifted its full-year outlook, citing 'strong momentum' into the holiday quarter. The firm now sees 2025 net sales up at least 34% YoY, ahead of prior guidance. Q3 earnings per share reached 0.43 CHF and revenue 794.4 million CHF, beating Street estimates. Growth was led by Asia-Pacific, where revenue surged as demand shifts toward premium offerings; the US market is expanding into tennis and training sneakers with younger consumers and influencers like Zendaya. Americas sales rose ~21%. The stock had fallen ~35% before the print, with some concern over Nike's turnaround, but On intends to chart its own premium path in global sportswear.
BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)
Previous Story

BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

Humacyte (HUMA) Q3 2025: Symvess Sales Surge; IND Filed for CABG as Dialysis Data Advance — Nov 12, 2025
Next Story

Humacyte (HUMA) Q3 2025: Symvess Sales Surge; IND Filed for CABG as Dialysis Data Advance — Nov 12, 2025

Go toTop